China Merchants China Direct Investments Limited operates within the Investment offices sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Merchants China Direct Investments Limited with three other
financial institutions in Asia:
Chemon Inc
of KOREA (SOUTH)
(2019
sales of 20.91 billion Korean Won [US$17.53 million]
of which 82%
was Safety Service),
Dolat Investments Limited
of INDIA
(1.16 billion Indian Rupees [US$15.43 million]
), and
Selvas Healthcare Inc
which is
based in KOREA (SOUTH)
(22.35 billion Korean Won [US$18.73 million]
of which 55%
was AT).
Sales Analysis.
During the year ended December of 2019, sales at
China Merchants China Direct Investments Limited were HK$121.65 million (US$15.70 million).
This
is
a
decrease of 17.8%
versus 2018, when the company's sales were HK$148.02 million.
The sales level in 2019 was fairly close to the level five years ago: in 2014, China Merchants China Direct Investments Limited had sales
of HK$132.26 million.
Contributing to the drop in overall sales was the 36.5% decline
in Financial Services, from HK$122.64 million to HK$77.82 million.
.
However, these declines were partially offset by the increase in sales of
Culture, Media and Consumption (up 87.6% to HK$35.96 million)
and
Information Technology (up 41.6% to HK$773,677.94 )
.